Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

allogeneic GM-CSF-secreting lethally irradiated prostate cancer vaccine

An allogeneic whole cell vaccine expressing human granulocyte macrophage-colony stimulating factor (GM-CSF) with potential antineoplastic activity. Tumor cells from prostate cancer patients are harvested and then genetically modified to secrete GM-CSF, an immune stimulatory growth factor that plays a key role in stimulating the body's immune responses against tumor cells. Because the vaccine is derived from allogenic cells, it has demonstrated a favorable side effect profile than other approaches of delivering long-lasting GM-CSF.
Synonym:allogeneic GM-CSF prostate cancer vaccine
allogeneic prostate cancer vaccine, GM- CSF gene transduced
allogeneic prostate cancer vaccine, GM-CSF gene transduced
allogeneic prostate GVAX
allogenic prostate GVAX
GM-CSF gene transduced allogeneic prostate cancer vaccine
GM-CSF prostate cancer vaccine
GVAX allogeneic prostate cancer vaccine
GVAX allogenic prostate cancer vaccine
GVAX prostate
GVAX prostate cancer vaccine
prostate cancer vaccine, GM-CSF gene transduced
prostate cancer vaccine, GVAX
Search NCI's Drug Dictionary